Addex Therapeutics Ltd
Organization details
- Legal name
- Addex Therapeutics Ltd
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Switzerland
- Headquarters city
- Geneva
- Headquarters country
- Switzerland
- Fiscal year end
- December
- Ticker symbol
- ADXN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001574232
Board of directors
-
Isaac Manke · DirectorSince 2026
-
Jason Raleigh Nunn · DirectorSince 2026
-
Raymond George Hill · DirectorSince 2026
-
Roger Mills · Director · CHIEF MEDICAL OFFICERSince 2026
-
Timothy Mark Dyer · Director · CHIEF EXECUTIVE OFFICERSince 2026
-
Vincent Michael Lawton · DirectorSince 2026
Chief executives
Board connections
2 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
OnKure Therapeutics Inc. Same sectorvia Isaac Manke
-
Q32 Bio Inc. Same sectorvia Isaac Manke
- via Isaac Manke
-
Zenas BioPharma Inc. Same sectorvia Jason Raleigh Nunn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Timothy Mark Dyer Director, Officer (CHIEF EXECUTIVE OFFICER) | Sold back to the company | −16,413,787 | — | — |
| Sep 2, 2026 | Raymond George Hill Director | Sold back to the company | −1,365,532 | — | — |
| Sep 2, 2026 | Vincent Michael Lawton Director | Sold back to the company | −2,507,487 | — | — |
| Sep 2, 2026 | Isaac Manke Director | Sold back to the company | −219,561 | — | — |
| Sep 2, 2026 | Roger Mills Director, Officer (CHIEF MEDICAL OFFICER) | Sold back to the company | −392,837 | — | — |
| Sep 2, 2026 | Jason Raleigh Nunn Director | Sold back to the company | −219,561 | — | — |
| Sep 2, 2026 | Kalinichev Mikhail Officer (HEAD OF TRANSLATIONAL SCIENCE) | Sold back to the company | −306,765 | — | — |
| Sep 2, 2026 | Timothy Mark Dyer Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant or award | +16,413,787 | — | — |
| Sep 2, 2026 | Raymond George Hill Director | Grant or award | +1,365,532 | — | — |
| Sep 2, 2026 | Vincent Michael Lawton Director | Grant or award | +2,507,487 | — | — |
| Sep 2, 2026 | Isaac Manke Director | Grant or award | +219,561 | — | — |
| Sep 2, 2026 | Roger Mills Director, Officer (CHIEF MEDICAL OFFICER) | Grant or award | +392,837 | — | — |
| Sep 2, 2026 | Jason Raleigh Nunn Director | Grant or award | +219,561 | — | — |
| Sep 2, 2026 | Kalinichev Mikhail Officer (HEAD OF TRANSLATIONAL SCIENCE) | Grant or award | +306,765 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Addex Therapeutics Ltd
Who is the CEO of Addex Therapeutics Ltd?
Timothy Mark Dyer has been Addex Therapeutics Ltd's Chief Executive Officer since March 2026.
How many directors are on Addex Therapeutics Ltd's board?
Addex Therapeutics Ltd's board has 6 directors: Isaac Manke, Jason Raleigh Nunn, Raymond George Hill, Roger Mills, Timothy Mark Dyer and Vincent Michael Lawton.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="addex-therapeutics-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.